Selected article for: "aging process and cc NC ND International license"

Author: T. Kuhn; T. Kaufmann; N.T. Doan; L.T. Westlye; J. Jones; R.A. Nunez; S.Y. Bookheimer; E.J. Singer; C.H. Hinkin; A.D. Thames
Title: An Augmented Aging Process in Brain White Matter in HIV
  • Document date: 2018_2_14
  • ID: 8izuaesr_24
    Snippet: These findings suggest that the impact of early disease burden, even among a sample comprised of 11% of participants with currently detectable HIV RNA viral load, has adverse effects on brain/cognition as HIV+ individuals age. This provides further support of previous findings 9, that demonstrated this augmented aging effect in a sample with no participants with detectable HIV RNA. The relationship of the past plasma viral load to current brain r.....
    Document: These findings suggest that the impact of early disease burden, even among a sample comprised of 11% of participants with currently detectable HIV RNA viral load, has adverse effects on brain/cognition as HIV+ individuals age. This provides further support of previous findings 9, that demonstrated this augmented aging effect in a sample with no participants with detectable HIV RNA. The relationship of the past plasma viral load to current brain reservoirs of HIV are not known, and we can only speculate that persons with a higher plasma viral burden in blood may have also acquired more viral seeding in brain; this may be the stimulus for greater neuroinflammation and more neurodegeneration over years of exposure. Taken together, these findings may suggest . CC-BY-NC-ND 4.0 International license is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/265199 doi: bioRxiv preprint Kuhn, T., Ph.D. 16 that HIV is associated with an augmented aging process in WM which is itself associated with lower cognitive performance.

    Search related documents:
    Co phrase search for related documents
    • adverse effect and age process: 1
    • adverse effect and cc NC ND International license: 1
    • adverse effect and cognitive performance: 1, 2
    • adverse effect and disease burden: 1, 2, 3, 4
    • adverse effect and exposure year: 1
    • age effect and cc NC ND International license: 1
    • age effect and cognitive performance: 1
    • age effect and disease burden: 1, 2, 3, 4, 5, 6
    • age process and cc NC ND International license: 1, 2, 3
    • age process and disease burden: 1
    • brain cognition and cognitive performance: 1, 2, 3, 4, 5, 6
    • brain cognition and disease burden: 1
    • cc NC ND International license and cognitive performance: 1
    • cc NC ND International license and disease burden: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cc NC ND International license and exposure year: 1
    • cognitive performance and disease burden: 1
    • disease burden and early disease burden: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • disease burden and early disease burden impact: 1
    • disease burden and exposure year: 1